M
MRKR
Marker Therapeut
1.400
-0.030-2.10%After Hours: 1.457 +0.057 +4.07%16:42 05/22 EDT
OPEN/PREV CLOSE1.400/1.430
TODAY RANGE1.400-1.469
VOL63.23K
MARKET CAP23.34M
52 WEEK RANGE0.8099-4.070
AVG VOL (3M)114.94K
% TURNOVER0.38%
TURNOVER--
P/E (TTM)-2.1225
% RANGE4.85%
EPS(TTM)-0.6596
P/E(FORWARD)-1.6867
P/B1.695
BVPS0.8261
DIVIDEND--
P/S6.59
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP22.06M
SHARES OUTSTANDING16.67M
NEXT EARNINGS08/12-08/17
FREE FLOAT15.76M
LOT SIZE1
EX-DATE01/27/2023
News
Press Releases
Financial Reports
Profile
Benzinga·05/15 22:08
Marker Therapeutics Q1 EPS $(0.16) Beats $(0.18) Estimate
TipRanks·05/04 22:34
Marker Therapeutics Shareholders Approve Governance and Capital Changes
Reuters·03/18 21:42
Marker Therapeutics 2025 net loss widens, hurt by decline in grant income
TipRanks·03/18 21:35
Marker Therapeutics reports FY25 EPS (79c), two estimates (94c)
Seeking Alpha·03/18 21:34
Marker Therapeutics GAAP EPS of -$0.79 beats by $0.15, revenue of $3.55M beats by $0.45M
Dow Jones·03/18 21:32
*Marker Therapeutics 2025 Rev $3.5M >MRKR
Dow Jones·03/18 21:32
*Marker Therapeutics 2025 Loss/Shr 79c >MRKR
Reuters·03/18 21:31
MARKER THERAPEUTICS FY NET INCOME USD -12.2 MILLION